Cargando…
In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori
Helicobacter pylori is one of the most frequent human pathogens and a leading etiological agent of various gastric diseases. As stringent response, coordinated by a SpoT protein, seems to be crucial for the survivability of H. pylori, the main goal of this article was to use in silico computational...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746548/ https://www.ncbi.nlm.nih.gov/pubmed/35011255 http://dx.doi.org/10.3390/molecules27010020 |
_version_ | 1784630613485027328 |
---|---|
author | Spiegel, Maciej Krzyżek, Paweł Dworniczek, Ewa Adamski, Ryszard Sroka, Zbigniew |
author_facet | Spiegel, Maciej Krzyżek, Paweł Dworniczek, Ewa Adamski, Ryszard Sroka, Zbigniew |
author_sort | Spiegel, Maciej |
collection | PubMed |
description | Helicobacter pylori is one of the most frequent human pathogens and a leading etiological agent of various gastric diseases. As stringent response, coordinated by a SpoT protein, seems to be crucial for the survivability of H. pylori, the main goal of this article was to use in silico computational studies to find phytochemical compounds capable of binding to the active site of SpoT from H. pylori and confirm the ability of the most active candidates to interfere with the virulence of this bacterium through in vitro experiments. From 791 natural substances submitted for the virtual screening procedure, 10 were chosen and followed for further in vitro examinations. Among these, dioscin showed the most interesting parameters (the lowest MIC, the highest anti-biofilm activity in static conditions, and a relatively low stimulation of morphological transition into coccoids). Therefore, in the last part, we extended the research with a number of further experiments and observed the ability of dioscin to significantly reduce the formation of H. pylori biofilm under Bioflux-generated flow conditions and its capacity for additive enhancement of the antibacterial activity of all three commonly used antibiotics (clarithromycin, metronidazole, and levofloxacin). Based on these results, we suggest that dioscin may be an interesting candidate for new therapies targeting H. pylori survivability and virulence. |
format | Online Article Text |
id | pubmed-8746548 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87465482022-01-11 In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori Spiegel, Maciej Krzyżek, Paweł Dworniczek, Ewa Adamski, Ryszard Sroka, Zbigniew Molecules Article Helicobacter pylori is one of the most frequent human pathogens and a leading etiological agent of various gastric diseases. As stringent response, coordinated by a SpoT protein, seems to be crucial for the survivability of H. pylori, the main goal of this article was to use in silico computational studies to find phytochemical compounds capable of binding to the active site of SpoT from H. pylori and confirm the ability of the most active candidates to interfere with the virulence of this bacterium through in vitro experiments. From 791 natural substances submitted for the virtual screening procedure, 10 were chosen and followed for further in vitro examinations. Among these, dioscin showed the most interesting parameters (the lowest MIC, the highest anti-biofilm activity in static conditions, and a relatively low stimulation of morphological transition into coccoids). Therefore, in the last part, we extended the research with a number of further experiments and observed the ability of dioscin to significantly reduce the formation of H. pylori biofilm under Bioflux-generated flow conditions and its capacity for additive enhancement of the antibacterial activity of all three commonly used antibiotics (clarithromycin, metronidazole, and levofloxacin). Based on these results, we suggest that dioscin may be an interesting candidate for new therapies targeting H. pylori survivability and virulence. MDPI 2021-12-21 /pmc/articles/PMC8746548/ /pubmed/35011255 http://dx.doi.org/10.3390/molecules27010020 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Spiegel, Maciej Krzyżek, Paweł Dworniczek, Ewa Adamski, Ryszard Sroka, Zbigniew In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori |
title | In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori |
title_full | In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori |
title_fullStr | In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori |
title_full_unstemmed | In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori |
title_short | In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori |
title_sort | in silico screening and in vitro assessment of natural products with anti-virulence activity against helicobacter pylori |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746548/ https://www.ncbi.nlm.nih.gov/pubmed/35011255 http://dx.doi.org/10.3390/molecules27010020 |
work_keys_str_mv | AT spiegelmaciej insilicoscreeningandinvitroassessmentofnaturalproductswithantivirulenceactivityagainsthelicobacterpylori AT krzyzekpaweł insilicoscreeningandinvitroassessmentofnaturalproductswithantivirulenceactivityagainsthelicobacterpylori AT dworniczekewa insilicoscreeningandinvitroassessmentofnaturalproductswithantivirulenceactivityagainsthelicobacterpylori AT adamskiryszard insilicoscreeningandinvitroassessmentofnaturalproductswithantivirulenceactivityagainsthelicobacterpylori AT srokazbigniew insilicoscreeningandinvitroassessmentofnaturalproductswithantivirulenceactivityagainsthelicobacterpylori |